New Directions in Triple-Negative Breast Cancer Diagnostics
A novel PD-L1 assay advances the promise of precision medicine.
Read MorePosted by Steve Halasey | Nov 6, 2019 | Breast, Lymphoma |
A novel PD-L1 assay advances the promise of precision medicine.
Read MorePosted by Steve Halasey | Oct 8, 2019 | Culture Media, Cytology, Histology, Leukemia, Lymphoma, Microscopy, Slides, Software |
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
Read MorePosted by Steve Halasey | Sep 17, 2019 | Leukemia, Microarray Systems |
Strong concordance with standard-of-care methods shows how the Saphyr mapping system can transform cytogenetic workflows and improve blood cancer treatment.
Read MorePosted by Steve Halasey | Aug 27, 2019 | Immunoassay |
Immunoassays for the detection of antibodies against Borrelia burgdorferi and Epstein-Barr virus are now available on the Euroimmun RA 10 analyzer.
Read MorePosted by Steve Halasey | Aug 26, 2019 | Breast, Cytology, Histology, Leukemia, Lung Cancer, Melanoma, Molecular Diagnostics, Prostate |
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read More